Irish clinical trial reveals new treatment option for COVID-

An anti-inflammatory protein, alpha-1 antitryspin, may treat patients who have developed acute respiratory distress syndrome as a result of COVID-19

Related Keywords

Ireland , Dublin , Irish , Oliver Mcelvaney , Gerry Mcelvaney , Natalie Mcevoy , Department Of Critical Care , University Of Medicine , Department Of Anaesthetics , Senior Clinical Research Nurse , Ireland University , Department Of Medicine , Royal College Of Surgeons , Health Sciences , Royal College , Beaumont Hospital , Critical Care , Professor Ger Curley ,